As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 3/21/24  Orbimed Advisors LLC              SC 13D/A               2:247K Adicet Bio, Inc.                  Shearman & Sterling LLP  
          Carl L. Gordon³
          Erez Chimovits³
          Orbimed Advisors Israel II Ltd.³
          OrbiMed Capital GP V LLC³
          OrbiMed Capital GP VI LLC³
          OrbiMed Genesis GP LLC³
          OrbiMed Israel BioFund GP Limited Partnership³
          OrbiMed Israel GP II, L.P.³
          OrbiMed Israel GP Ltd.³
 1/29/24  Orbimed Advisors LLC              SC 13D/A               2:253K Adicet Bio, Inc.                  Shearman & Sterling LLP  
          Carl L. Gordon³
          Erez Chimovits³
          Orbimed Advisors Israel II Ltd.³
          OrbiMed Capital GP V LLC³
          OrbiMed Capital GP VI LLC³
          OrbiMed Genesis GP LLC³
          OrbiMed Israel BioFund GP Limited Partnership³
          OrbiMed Israel GP II, L.P.³
          OrbiMed Israel GP Ltd.³
12/14/21  Orbimed Advisors LLC              SC 13D/A               3:234K Adicet Bio, Inc.                  Shearman & Sterling LLP  
          Orbimed Advisors Israel II Ltd.³
          OrbiMed Capital GP V LLC³
          OrbiMed Capital GP VI LLC³
          OrbiMed Genesis GP LLC³
          OrbiMed Israel BioFund GP Limited Partnership³
          OrbiMed Israel GP II, L.P.³
          OrbiMed Israel GP Ltd.³
 2/19/21‡ Orbimed Advisors LLC              SC 13D/A               3:205K Adicet Bio, Inc.                  Shearman & Sterling LLP  
          Orbimed Advisors Israel II Ltd.³
          OrbiMed Capital GP V LLC³
          OrbiMed Capital GP VI LLC³
          OrbiMed Israel BioFund GP Limited Partnership³
          OrbiMed Israel GP II, L.P.³
          OrbiMed Israel GP Ltd.³
 9/18/20  Orbimed Advisors LLC              SC 13D/A               2:195K Adicet Bio, Inc.                  Shearman & Sterling LLP  
          Orbimed Advisors Israel II Ltd.³
          OrbiMed Capital GP V LLC³
          OrbiMed Capital GP VI LLC³
          OrbiMed Israel BioFund GP Limited Partnership³
          OrbiMed Israel GP II, L.P.³
          OrbiMed Israel GP Ltd.³

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Type:  -K
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.